Psilocybin-Assisted Therapy for Intergenerational Trauma
This is an open-label psilocybin-assisted therapy study that will examine the safety and tolerability of psilocybin-assisted therapy in the offspring of genocide survivors with mood and anxiety disorders. The study will also investigate the efficacy of psilocybin-assisted therapy in reducing symptoms such as depression, anxiety and stress, as well as changes to the psychological effects of parental exposure to genocide, and changes to psychological resilience.
Age at least 18 years old at time of signing the informed consent. [+14]
Individual was directly exposed to the genocide. [+29]